U.S. Court Ruling Favors Cubist in Patent Case vs HospiraU.S. Court Ruling Favors Cubist in Patent Case vs Hospira

A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin (daptomycin injection) by Hospira Inc. Reuters Health Information

Source: Medscape Today Headlines - May 21, 2013 Category: Consumer Health News Tags: Pharmacist News Source Type: news